2cureX AB engages in the research and development of anti-cancer treatments. It offers IndiTreat, which is a tool that determines treatment methods on individual colorectal cancer patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Copenhagen, Denmark.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company